GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » FCF Yield %

TOT Biopharm International Co (HKSE:01875) FCF Yield % : -10.36 (As of Mar. 03, 2025)


View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, TOT Biopharm International Co's Trailing 12-Month Free Cash Flow is HK$-135 Mil, and Market Cap is HK$1,305 Mil. Therefore, TOT Biopharm International Co's FCF Yield % for today is -10.36%.

The historical rank and industry rank for TOT Biopharm International Co's FCF Yield % or its related term are showing as below:

HKSE:01875' s FCF Yield % Range Over the Past 10 Years
Min: -30.57   Med: -14.59   Max: -8.12
Current: -10.36


During the past 7 years, the highest FCF Yield % of TOT Biopharm International Co was -8.12%. The lowest was -30.57%. And the median was -14.59%.

HKSE:01875's FCF Yield % is ranked better than
55.46% of 1502 companies
in the Biotechnology industry
Industry Median: -14.15 vs HKSE:01875: -10.36

TOT Biopharm International Co's FCF Margin % for the quarter that ended in Jun. 2024 was -7.89%.


TOT Biopharm International Co FCF Yield % Historical Data

The historical data trend for TOT Biopharm International Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co FCF Yield % Chart

TOT Biopharm International Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -12.81 -12.77 -14.48 -11.56 -11.24

TOT Biopharm International Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.77 -19.35 -8.60 -12.74 -5.57

Competitive Comparison of TOT Biopharm International Co's FCF Yield %

For the Biotechnology subindustry, TOT Biopharm International Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOT Biopharm International Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TOT Biopharm International Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where TOT Biopharm International Co's FCF Yield % falls into.



TOT Biopharm International Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

TOT Biopharm International Co's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-160.533 / 1428.63809
=-11.24%

TOT Biopharm International Co's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-44.194 * 2 / 1588.18143
=-5.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOT Biopharm International Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


TOT Biopharm International Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


TOT Biopharm International Co Business Description

Traded in Other Exchanges
N/A
Address
120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.
Executives
Center Laboratories, Inc. 2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited 2301 Trustee
Chengwei Evergreen Capital, Lp 2101 Beneficial owner
Center Laboratories Inc. 2101 Beneficial owner
Chengwei Evergreen Management, Llc 2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited 2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines